Variant report
Variant | nsv523612 |
---|---|
Chromosome Location | chr8:124855776-124857300 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1431671 | chr8:124855776-124855777 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs577839136 | chr8:124855787-124855788 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186568489 | chr8:124855795-124855796 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190770027 | chr8:124855807-124855808 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553692233 | chr8:124855835-124855836 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183010518 | chr8:124855906-124855907 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543268368 | chr8:124855921-124855922 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550219119 | chr8:124855929-124855930 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563082502 | chr8:124855954-124855955 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs151335783 | chr8:124856100-124856101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12543266 | chr8:124856155-124856156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565024401 | chr8:124856184-124856185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527746724 | chr8:124856197-124856198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs16898956 | chr8:124856199-124856200 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs561288483 | chr8:124856206-124856207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371271687 | chr8:124856239-124856240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530049658 | chr8:124856357-124856358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549249676 | chr8:124856360-124856361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188709896 | chr8:124856382-124856383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546930104 | chr8:124856412-124856413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538014509 | chr8:124856461-124856462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376322223 | chr8:124856507-124856508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560817463 | chr8:124856508-124856509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113408242 | chr8:124856524-124856525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs397955125 | chr8:124856532-124856533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56780889 | chr8:124856559-124856560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551634676 | chr8:124856678-124856679 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150469282 | chr8:124856710-124856711 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79064163 | chr8:124856770-124856771 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375892303 | chr8:124856776-124856777 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145355491 | chr8:124856817-124856818 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562512822 | chr8:124856862-124856863 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573574692 | chr8:124856907-124856908 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142500669 | chr8:124856913-124856914 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377649873 | chr8:124856933-124856934 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71289615 | chr8:124856944-124856945 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs59550691 | chr8:124856974-124856975 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537219277 | chr8:124856995-124856996 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531857028 | chr8:124856997-124856998 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532209918 | chr8:124857045-124857046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs199778475 | chr8:124857053-124857054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549666584 | chr8:124857054-124857055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556420577 | chr8:124857056-124857057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551565079 | chr8:124857082-124857083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576363962 | chr8:124857107-124857108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192612638 | chr8:124857114-124857115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6987803 | chr8:124857128-124857129 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs183352074 | chr8:124857142-124857143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572308821 | chr8:124857144-124857145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568948509 | chr8:124857180-124857181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 20932292 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 22056952 | CNVD |
Langer-Giedion syndrome | 16773131 | CNVD |
Lung cancer | 16740712 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Langer-Giedion syndrome | 22470819 | CNVD |
Cornelia de Lange syndrome | 24599119 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 16397240 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Breast cancer | 21364760 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Breast cancer | 21611746 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian cancer | 21240255 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:124852800-124856800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr8:124853000-124856600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr8:124853400-124856600 | Weak transcription | NHEK | skin |
4 | chr8:124853600-124856600 | Weak transcription | HMEC | breast |
5 | chr8:124854200-124856000 | ZNF genes & repeats | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr8:124855200-124855800 | Enhancers | Fetal Intestine Large | intestine |
7 | chr8:124855200-124856000 | Enhancers | Duodenum Mucosa | Duodenum |
8 | chr8:124855200-124856800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr8:124855400-124855800 | Enhancers | Fetal Intestine Small | intestine |
10 | chr8:124855800-124856600 | Weak transcription | Fetal Intestine Small | intestine |
11 | chr8:124856000-124856400 | Weak transcription | Duodenum Mucosa | Duodenum |
12 | chr8:124856000-124856600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr8:124856400-124856800 | Enhancers | Duodenum Mucosa | Duodenum |
14 | chr8:124856600-124856800 | Enhancers | Fetal Intestine Small | intestine |
15 | chr8:124856600-124857000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr8:124856600-124857400 | Enhancers | Small Intestine | intestine |
17 | chr8:124856600-124857600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr8:124856600-124857600 | Enhancers | HMEC | breast |
19 | chr8:124856600-124857600 | Enhancers | NHEK | skin |
20 | chr8:124856800-124857600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
21 | chr8:124856800-124857600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
22 | chr8:124857000-124857200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr8:124857200-124857400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |